CK Life Sciences Intl (Holdings) Inc

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
TransCode Therapeutics, Inc. 13D/A Amendment 5 RNAZ · 89357L501	RNAZ	89357L501	83.9%	14,134,481	13D/A Amendment 5	8/3/2026 Event 8/3/2026
Defj, LLC			83.9%	14,134,481
CK Life Sciences Int'l., (Holdings) Inc.			83.9%	14,134,481
Transcode Therapeutics, Inc. 13D/A Amendment 4 RNAZ · 89357L501	RNAZ	89357L501	83.9%	14,134,481	13D/A Amendment 4	7/27/2026 Event 7/27/2026
Defj, LLC			83.9%	14,134,481
CK Life Sciences Int'l., (Holdings) Inc.			83.9%	14,134,481
TransCode Therapeutics, Inc. 13D/A Amendment 3 RNAZ · 89357L501	RNAZ	89357L501	9.9%	300,040	13D/A Amendment 3	7/23/2026 Event 7/23/2026
Defj, LLC			9.9%	300,040
CK Life Sciences Int'l., (Holdings) Inc.			9.9%	300,040
TransCode Therapeutics, Inc. 13D/A Amendment 2 RNAZ · 89357L501	RNAZ	89357L501	8.8%	83,285	13D/A Amendment 2	7/17/2026 Event 7/17/2026
Defj, LLC			8.8%	83,285
CK Life Sciences Int'l., (Holdings) Inc.			8.8%	83,285
TransCode Therapeutics, Inc. 13D/A Amendment 1 RNAZ · 89357L501	RNAZ	89357L501	9.1%	83,285	13D/A Amendment 1	10/28/2025 Event 10/27/2025
CK Life Sciences Int'l., (Holdings) Inc.			9.1%	83,285
Defj, LLC			9.1%	83,285
TransCode Therapeutics, Inc. 13D RNAZ · 89357L501	RNAZ	89357L501	9.1%	83,285	13D	10/16/2025 Event 10/8/2025
CK Life Sciences Int'l., (Holdings) Inc.			9.1%	83,285
Defj, LLC			9.1%	83,285

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.